CINA CHEST vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA CHEST

by Avicenna.AI

Tempus ECG-AF

by Tempus AI, Inc.

AI Verdict

CINA CHEST is designed for rapid radiological triage of acute, life-threatening conditions like pulmonary embolism and aortic dissection using CT scans. In contrast, Tempus ECG-AF focuses on identifying older patients at risk of developing atrial fibrillation within the next year by analyzing ECG recordings. Therefore, CINA CHEST is suited for emergency imaging workflows, while Tempus ECG-AF supports proactive cardiac risk management.

Choose CINA CHEST if…

Choose CINA CHEST if your emergency department or radiology practice requires immediate AI-powered triage and notification for life-threatening acute chest conditions. This tool is ideal for rapidly detecting suspected Pulmonary Embolism or Aortic Dissection on CT angiography scans, enabling faster prioritization of critical cases within a high-volume workflow.

View CINA CHEST →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your cardiology, geriatrics, or internal medicine practice aims to proactively identify older adult patients at increased risk of developing atrial fibrillation within the next year. This AI-based solution integrates with existing 12-lead ECG systems to support earlier identification and follow-up for patients aged 65 or older without pre-existing AF.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA CHEST	Tempus ECG-AF
Pricing	Subscription-based	Contact vendor
Deployment	Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available	Unknown	Yes AI-estimated
FDA Status	K210237 AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CINA CHEST

CINA CHEST operates as a standalone web application and provides notifications with compressed preview images, suggesting a streamlined interface for rapid radiological triage. While Tempus ECG-AF integrates into existing systems, its results require interpretation in conjunction with other clinical data, potentially adding a step to the user workflow.

Clinical Value

CINA CHEST

CINA CHEST focuses on the rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism and Aortic Dissection in emergency settings, directly impacting immediate patient outcomes. Tempus ECG-AF provides valuable predictive risk for Atrial Fibrillation, enabling proactive management, but CINA CHEST's impact on acute, critical care scenarios gives it a slight edge in immediate clinical urgency.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF offers clear transparency regarding CMS reimbursement, with specific CPT codes and a Medicare rate provided, which significantly aids healthcare facilities in understanding the financial viability of implementation. CINA CHEST's pricing is subscription-based with details available only upon request, making its value proposition less transparent upfront.

Enterprise Readiness

CINA CHEST

Both tools are FDA-cleared and HIPAA compliant, indicating a strong foundation for enterprise use. However, CINA CHEST offers more flexible deployment options, including cloud-based, on-premise (dedicated hardware), and virtualized (VM, Docker) solutions, which can accommodate a wider range of IT infrastructures and preferences within a healthcare enterprise.

Innovation

Tempus ECG-AF

Tempus ECG-AF demonstrates significant innovation by leveraging AI to predict the risk of new-onset Atrial Fibrillation within 12 months from standard 12-lead ECG recordings, a widely available and inexpensive diagnostic test. While CINA CHEST's real-time triage for acute conditions is also innovative, the predictive capability from a common, non-invasive test for proactive patient management represents a novel application of AI in cardiovascular care.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information from web searches offer specific details regarding the level of support, documentation, training, or service level agreements for either CINA CHEST or Tempus ECG-AF. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA CHEST	Tempus ECG-AF
Name	CINA CHEST	Tempus ECG-AF
Company	Avicenna.AI	Tempus AI, Inc.
Primary Purpose	AI-powered radiological triage and notification software for rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans.	AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Target Condition(s)	Pulmonary Embolism (PE), Aortic Dissection (AD)	Atrial Fibrillation/Flutter (AF)
Input Data Type	CT angiography scans (Chest, Thoraco-abdominal)	12-lead ECG recordings

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and Tempus ECG-AF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do CINA CHEST and Tempus ECG-AF integrate with existing clinical workflows and EHR systems, and what is the expected impact on a physician's daily routine?

CINA CHEST operates as a standalone web application, providing notifications with compressed preview images to assist in radiological workflow triage. Tempus ECG-AF is a software solution designed to integrate with existing ECG platforms and EHRs, enabling advanced AI deployment and insights within clinical workflows, and is compatible with FDA-authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.

Beyond their stated specialties, what specific clinical scenarios and patient populations are each tool best suited for, and how do they directly aid physician decision-making in those contexts?

CINA CHEST is best suited for emergency radiology, providing rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans to assist in urgent triage. Tempus ECG-AF is intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to identify an increased risk of developing AF within 12 months, supporting earlier identification and follow-up in cardiology, geriatrics, and internal medicine.

What level of accuracy and performance can be expected from CINA CHEST for PE/AD detection and Tempus ECG-AF for AF risk identification, based on their design and training?

CINA CHEST demonstrated a sensitivity of 91.1% and specificity of 91.8% for PE, and 96.4% sensitivity and 97.5% specificity for AD detection in a retrospective study. Tempus ECG-AF, trained on over 1.5 million ECGs from over 500,000 patients, showed a sensitivity of 31% and specificity of 92% for classifying patients who developed clinically recognized AF within one year.

What is the anticipated learning curve for physicians and clinical staff to proficiently use each AI tool, and what training or onboarding support is typically provided?

CINA CHEST operates as a standalone web application with notifications, suggesting a focused learning curve for its triage interface. Tempus ECG-AF is designed for integration into existing ECG platforms and EHRs, which may reduce the need for extensive new interface training as it aims to work within current clinical workflows.

What is the expected time-to-value for each solution, and how quickly can a physician anticipate seeing tangible improvements in patient outcomes or workflow efficiency?

CINA CHEST aims for rapid detection and prioritization in emergency settings, with processing times for results around 1.5 minutes for incidental PE, suggesting immediate value in accelerating triage for critical conditions. Tempus ECG-AF provides results almost immediately after ECG data is fed into the system, offering value over time through proactive patient management and earlier identification of AF risk for follow-up.

For healthcare systems with multiple sites, what are the key considerations for a successful multi-site rollout and ongoing management of each AI solution?

CINA CHEST is designed to assist hospital networks and offers flexible deployment options including cloud, on-premise, or virtualized environments, implying scalability across multiple sites. Tempus ECG-AF is integrated into healthcare facility systems and is being deployed by institutions like Northwestern Medicine across their care teams, suggesting considerations for integration with existing infrastructure and cardiology workflows in multi-site rollouts.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring CINA CHEST or Tempus ECG-AF

Backers

Who funded each tool's parent company.